MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2026 International Congress

    Non-Motor Symptoms in Hemifacial Spasm: A Cross-Sectional Study from a Brazilian Public Tertiary Center

    M. Soares, M. Silva, JA. de Albuquerque, C. Franco, PA. Rocha Filho (Recife, Brazil)

    Objective: To determine clinical characteristics of non-motor symptoms in patients with primary hemifacial spasm (HFS) at a tertiary public center in Brazil. Background: HFS is…
  • 2026 International Congress

    Sialorrhoea As An Indicator Of Palliative Phase In Advanced Parkinson’s

    R. Biju, K. Kaur, B. Mohamed, J. Adenwalla, C. Thomas, S. Aviet (Cardiff, United Kingdom)

    Objective: 1. To assess whether sialorrhoea severity at referral correlates with advanced Parkinson's 2. Evaluate survival outcomes following clinic attendance3. Explore the potential role of sialorrhoea…
  • 2026 International Congress

    IncobotulinumtoxinA to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 7-year Interim Results

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, M. van Zandijcke (Bruges, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles (IC)). Background: Sialorrhea…
  • 2026 International Congress

    Are All Toxins Created Equal? Real-world analysis of Abo-, Inco- and Ona- BoNT-A from prospective LIVEchart over 7 years

    R. Ellis, A. Moore (Liverpool, United Kingdom)

    Objective: To compare dosing, duration of action, and patient-reported outcomes across inco-, abo- and ona- BoNT (botulinum toxin) in cervical dystonia (CD), hemifacial spasm (HFS),…
  • 2026 International Congress

    Postural Disorders in Parkinson’s Disease: The Role of Botulinum Toxin – A French prospective cohort

    M. Pougeon, C. Tourlet, S. Grimaldi, A. Eusebio, JP. Azulay, F. Fluchere (Marseille, France)

    Objective: The aim of this study was to evaluate the effect of botulinum toxin (BoNT) injections on postural evolution, pain, and functional outcomes in patients…
  • 2025 International Congress

    IncobotulinumtoxinA to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 6-year Interim Results

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, H. Couckuyt, L. Delameilleure, M. van Zandijcke (Bruges, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea. Background: Sialorrhea is frequently a…
  • 2025 International Congress

    Botulinium toxin in treatment of Parkinsonism

    A. Wankar (Nagpur, India)

    Objective: This review discusses the use of BT in various motor and non-motor symptoms of Parkinsonism. This review discusses the use of BT in various…
  • 2025 International Congress

    Management of Grisel’s Syndrome with Botulinum Toxin: A Case Report

    L. Kenjaeva, A. Azimov, G. Kendjaeva (Tashkent, Uzbekistan)

    Objective: To present a case of Grisel’s syndrome (GS), highlighting challenges and the efficacy of botulinum toxin therapy in treatment. Background: Grisel’s syndrome (GS) is…
  • 2025 International Congress

    Effectiveness, Safety, and Quality of Life Outcomes of Neurotoxin Injections in the Treatment of Essential Tremors: A Systematic Review

    YJ. Rabe, A. Yu, JR. Yu, D. Simpson (San Juan City, Philippines)

    Objective: This systematic review aims to evaluate the outcomes of neurotoxins such as botulinum neurotoxin (BoNT) injections as a therapeutic intervention for essential tremors with…
  • 2025 International Congress

    Lower Eyelids Botulinum Injections: Improving Dry Eye and Prolonging Therapeutic Effect

    M. Cohen, L. Berkovitz, H. Totah, Y. Shechter, G. Yahalom (jerusalem, Israel)

    Objective: This study explores botulinum toxin (BT) injection techniques to optimize outcomes for patients with facial disorders, focusing on improving dry eye. Background: Dry eye…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 15
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley